Abstract: A medical bed frame may include a base frame, a pair of side members selectively movable laterally towards or away from the base frame, a first and second drive assembly each comprising: a first and second pair of cams configured to move the pair of side members, and a central linkage for rotating the first and second pair of cams, a first actuator operatively connected to the central linkage of the first drive assembly and the base frame, and a second actuator operatively connected to the central linkage of the second drive assembly and the base frame, wherein the first and second actuator are configured to selectively move the central linkage in one of a first direction and a second direction, whereby selective movement of the first actuator and the second actuator results in lateral movement of the pair of side members towards or away from the base frame.

Abstract: Improved compilers recognize interception declarations in source code, and emit code that replaces invocations of specified artifacts with invocations of specified interceptors instead. Source generators proactively modify program behavior in arbitrary desired ways without introducing hidden security violations and without requiring edits by the program's developers. Interception declarations are visible in source code and development tools. In some cases, different invocations of a particular method at respective locations are intercepted by different replacement methods. Replacement methods have identical signatures, or are otherwise compatible. Some interceptors specify optional parameters. Method calls, field accesses, and property calls may be intercepted. Work to modify program behavior is moved in the program lifecycle from runtime to compile time, thus improving runtime performance and eliminating JIT compilation security risks.

Abstract: The present invention describes a method using temperature data to protect battery health during bidirectional charging in conjunction with monetization activities. The method includes receiving temperature data and determining anticipated energy needs of a building. The temperature data includes at least the temperature of one or more electric vehicle batteries or information required to determine the temperature of the one or more electric vehicle batteries while the anticipated energy needs are relative to ambient air temperature. The method includes determining an amount of discharge of the one or more electric vehicle batteries required to offset the anticipated needs of the building by a predetermined amount and determining based on the temperature data whether discharging the one or more electric vehicle batteries would be harmful to the health of the one or more electric vehicle batteries.

Abstract: An automatic dual pump assembly for a pumped refrigerant cooling system including a refrigerant reservoir for receiving a refrigerant fluid includes a first pump having a first pump inlet and a first pump outlet, a first variable frequency drive coupled to the first pump, a second pump having a second pump inlet and a second pump outlet, a second variable frequency drive coupled to the second pump, and a three-way valve having an input arm fluidly coupled to the refrigerant reservoir, a first outlet arm fluidly coupled to the first pump inlet, and a second outlet arm coupled to the second pump inlet. The first pump outlet and the second pump outlet are coupled to a refrigerant supply line, and the three-way valve selectively controls flow of the refrigerant fluid to one or both of the first pump and the second pump.

Abstract: Raw sensor data from a device of a user is collected. The raw data does not include location data for the device. The data is preprocessed to identify driving trips in which the user had the device. The trip data is provided to machine-learning models (MLMs) as input and the MLMs provide as output predictions for each trip's estimated speeds, estimated number of hard brakes and a degree of each hard brake, and estimated degrees of distracted driving. A duration, time of day, and calendar date of each trip is identified. The predictions, duration, time of day, and calendar date are modified into four factor values. The four modified factor values are combined into an overall driver characteristic value and provided to a network service associated with the user for purposes of providing or modifying services provided to the user through the network service based on the overall characteristic value.

Abstract: The present disclosure relates to non-surgical methods for delivery of an agent to the respiratory system of a subject, methods of treatment using delivery of agents to the respiratory system, devices for delivery of agents to the respiratory system, and use of such devices to deliver agents to the respiratory system. In certain embodiments, the present disclosure provides a provide a non-surgical method of delivering an agent to the respiratory system of a subject. The method comprises in vivo perturbation of the airway surface in one or more parts of the respiratory system in the subject and exposing the perturbed surface of the airway to the agent, thereby delivering the agent to the respiratory system of the subject.

Abstract: A method includes creating an object by consolidating a powder including providing a former member made from a soluble material soluble in a non-hazardous solvent for shaping the object, surrounding a portion of the former member with the powder, densifying the powder which surrounds the portion of the former member to form the object and dissolving the former member using a non-hazardous solvent to separate the object from the former member.

Abstract: Systems, methods, apparatuses, and computer-readable media are provided for rules execution testing using live production data. Live production authorization requests may be received at a production computing device. Production authorization decisions may be determined at the production computing device for the live production authorization requests using a set of production rules. The production authorization requests, data used to arrive at the corresponding production authorization decisions, and/or the corresponding authorization decisions may be streamed in real-time to a test device. Test authorization decisions may be determined at the test device for the received live production authorization requests using the received data used to arrive at the production authorization decisions, and using a set of test rules. Production and test authorization decisions may be compared to determine decision differences. One or more user interfaces or reports may be generated for outputting the decision differences.

Abstract: Systems, methods, apparatuses, and computer-readable media are provided for rules execution testing using live production data. Live production authorization requests may be received at a production computing device. Production authorization decisions may be determined at the production computing device for the live production authorization requests using a set of production rules. The production authorization requests, data used to arrive at the corresponding production authorization decisions, and/or the corresponding authorization decisions may be streamed in real-time to a test device. Test authorization decisions may be determined at the test device for the received live production authorization requests using the received data used to arrive at the production authorization decisions, and using a set of test rules. Production and test authorization decisions may be compared to determine decision differences. One or more user interfaces or reports may be generated for outputting the decision differences.

Abstract: Provided herein are microbial infection indicator devices, including dressing with indicators, standalone indicator inserts or disks that can be freely placed at a wound site or dressing, and applications thereof for displaying a visible or detectable signal to a user upon detection of an analyte or biomarker indicative of an infection, such as a color change.

Abstract: Systems and methods are provided for using augmented reality to create a printing template. The method includes capturing, using a camera of a mobile electronic device, a real world image of a surface. The method further includes, by a processor, receiving the real world image, processing the real world image to isolate and measure a portion of the surface on which print job content is to be applied, creating a printing template conforming to a shape and area of the isolated and measured portion of the surface, causing the real world image to be output on a display, and causing the display to output the printing template over the real world image, overlaid over the isolated and measured portion of the surface.

Abstract: The present disclosures describes a remotely controlled stereotactic radiotherapy system. The system may include a gamma-ray irradiation system for radioablation of a target region of human tissue, the system having an irradiating unit configured to produce a radiation field, and a processor remote from the gamma-ray irradiation system configured to control the dosage and position of the radiation field applied to the target region.

Abstract: Methods, processes and compositions are provided for improved wound dressings comprising an antimicrobial composition. The wound dressings maintain conformability and strength, as well as antimicrobial performance, upon use after storage.

Abstract: Systems, methods, apparatuses, and computer-readable media are provided for rules execution testing using live production data. Live production authorization requests may be received at a production computing device. Production authorization decisions may be determined at the production computing device for the live production authorization requests using a set of production rules. The production authorization requests, data used to arrive at the corresponding production authorization decisions, and/or the corresponding authorization decisions may be streamed in real-time to a test device. Test authorization decisions may be determined at the test device for the received live production authorization requests using the received data used to arrive at the production authorization decisions, and using a set of test rules. Production and test authorization decisions may be compared to determine decision differences. One or more user interfaces or reports may be generated for outputting the decision differences.

Abstract: A chemically modified cellulosic fibre or filament having a moisture content of at least 7% by weight obtained by a process comprising the steps of (i) obtaining cellulosic fibres or filament and chemically modifying the cellulose by substitution to increase its absorbency; (ii) washing the fibres after step (i) in a mixture comprising water and up to 99% by weight of water-miscible organic solvent; (iii) drying the fibres to a moisture content of at least 7% by weight.

Abstract: The present invention relates to an antimicrobial composition suitable for use on skin and wounds comprising a source of an antimicrobial metal ion and a quaternary cationic surfactant.

Abstract: A staining composition for use in making biofilm detectable on viable tissue wherein the composition preferentially stains the biofilm and comprises a staining agent in a quantity effective to stain said biofilm and render it detectable.

Abstract: Provided herein are microbial infection indicator devices, including dressing with indicators, standalone indicator inserts or disks that can be freely placed at a wound site or dressing, and applications thereof for displaying a visible or detectable signal to a user upon detection of an analyte or biomarker indicative of an infection, such as a color change.

Abstract: A staining composition for use in making biofilm detectable on viable tissue wherein the composition preferentially stains the biofilm and comprises a staining agent in a quantity effective to stain the biofilm and render it detectable.

Abstract: The disclosed technology relates to a wound dressing comprising an absorbent layer impregnated or coated with a composition comprising a chelating agent, an amphoteric surfactant, and an anionic surfactant. The invention further relates to methods and uses of the wound dressing.